Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Tuberculosis D014376 20 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Ruwisch L et al. An improved high-performance liquid chromatographic method for the determination of sphingosine-1-phosphate in complex biological materials. 2001 Naunyn Schmiedebergs Arch. Pharmacol. pmid:11284453
van der Weyden L et al. Genome-wide in vivo screen identifies novel host regulators of metastatic colonization. 2017 Nature pmid:28052056
Herzog BH et al. Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2. 2013 Nature pmid:23995678
Maceyka M and Spiegel S Sphingolipid metabolites in inflammatory disease. 2014 Nature pmid:24899305
Matloubian M et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. 2004 Nature pmid:14737169
Eisenhoffer GT et al. Crowding induces live cell extrusion to maintain homeostatic cell numbers in epithelia. 2012 Nature pmid:22504183
Vu TM et al. Mfsd2b is essential for the sphingosine-1-phosphate export in erythrocytes and platelets. 2017 Nature pmid:29045386
Olivera A and Spiegel S Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens. 1993 Nature pmid:8413613
Choi OH et al. Calcium mobilization via sphingosine kinase in signalling by the Fc epsilon RI antigen receptor. 1996 Nature pmid:8602265
Driever W Developmental biology. Bringing two hearts together. 2000 Nature pmid:10910341
Kupperman E et al. A sphingosine-1-phosphate receptor regulates cell migration during vertebrate heart development. 2000 Nature pmid:10910360
Ng CK et al. Drought-induced guard cell signal transduction involves sphingosine-1-phosphate. 2001 Nature pmid:11279499
Cuvillier O et al. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. 1996 Nature pmid:8657285
Martin R Multiple sclerosis: closing in on an oral treatment. 2010 Nature pmid:20237554
Mendoza A et al. Lymphatic endothelial S1P promotes mitochondrial function and survival in naive T cells. 2017 Nature pmid:28538737
Ishii M et al. Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. 2009 Nature pmid:19204730
Alvarez SE et al. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. 2010 Nature pmid:20577214
Coursol S et al. Sphingolipid signalling in Arabidopsis guard cells involves heterotrimeric G proteins. 2003 Nature pmid:12789341
Blaho VA et al. HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation. 2015 Nature pmid:26053123
Wymann MP and Schneiter R Lipid signalling in disease. 2008 Nat. Rev. Mol. Cell Biol. pmid:18216772
Spiegel S and Milstien S Sphingosine-1-phosphate: an enigmatic signalling lipid. 2003 Nat. Rev. Mol. Cell Biol. pmid:12728273
Hannun YA and Obeid LM Principles of bioactive lipid signalling: lessons from sphingolipids. 2008 Nat. Rev. Mol. Cell Biol. pmid:18216770
Rivera J et al. The alliance of sphingosine-1-phosphate and its receptors in immunity. 2008 Nat. Rev. Immunol. pmid:18787560
Rosen H and Goetzl EJ Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. 2005 Nat. Rev. Immunol. pmid:15999095
Spiegel S and Milstien S The outs and the ins of sphingosine-1-phosphate in immunity. 2011 Nat. Rev. Immunol. pmid:21546914
Fletcher JI et al. ABC transporters in cancer: more than just drug efflux pumps. 2010 Nat. Rev. Cancer pmid:20075923
Ogretmen B Sphingolipid metabolism in cancer signalling and therapy. 2018 Nat. Rev. Cancer pmid:29147025
Ogretmen B and Hannun YA Biologically active sphingolipids in cancer pathogenesis and treatment. 2004 Nat. Rev. Cancer pmid:15286740
Pyne NJ and Pyne S Sphingosine 1-phosphate and cancer. 2010 Nat. Rev. Cancer pmid:20555359
Hait NC et al. Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory. 2014 Nat. Neurosci. pmid:24859201
Lobo MK et al. Genetic control of instrumental conditioning by striatopallidal neuron-specific S1P receptor Gpr6. 2007 Nat. Neurosci. pmid:17934457
Chimen M et al. Homeostatic regulation of T cell trafficking by a B cell-derived peptide is impaired in autoimmune and chronic inflammatory disease. 2015 Nat. Med. pmid:25894827
Barnes PJ Ceramide lances the lungs. 2004 Nat. Med. pmid:14760419
Casper RF and Jurisicova A Protecting the female germ line from cancer therapy. 2000 Nat. Med. pmid:11017136
Morita Y et al. Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. 2000 Nat. Med. pmid:11017141
Paris F et al. Sphingosine 1-phosphate preserves fertility in irradiated female mice without propagating genomic damage in offspring. 2002 Nat. Med. pmid:12205432
Petrache I et al. Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. 2005 Nat. Med. pmid:15852018
Cantalupo A et al. Nogo-B regulates endothelial sphingolipid homeostasis to control vascular function and blood pressure. 2015 Nat. Med. pmid:26301690
Garris CS et al. Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation. 2013 Nat. Immunol. pmid:24076635
Fang V et al. Gradients of the signaling lipid S1P in lymph nodes position natural killer cells and regulate their interferon-γ response. 2017 Nat. Immunol. pmid:27841869
Walzer T et al. Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. 2007 Nat. Immunol. pmid:17965716
Wei SH et al. Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses. 2005 Nat. Immunol. pmid:16273098
Liu G et al. The S1P(1)-mTOR axis directs the reciprocal differentiation of T(H)1 and T(reg) cells. 2010 Nat. Immunol. pmid:20852647
Ramos-Perez WD et al. A map of the distribution of sphingosine 1-phosphate in the spleen. 2015 Nat. Immunol. pmid:26502404
Schwab SR and Cyster JG Finding a way out: lymphocyte egress from lymphoid organs. 2007 Nat. Immunol. pmid:18026082
Ledgerwood LG et al. The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics. 2008 Nat. Immunol. pmid:18037890
Sanna MG et al. Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo. 2006 Nat. Chem. Biol. pmid:16829954
Mullershausen F et al. Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors. 2009 Nat. Chem. Biol. pmid:19430484
Cahalan SM et al. Actions of a picomolar short-acting S1P₁ agonist in S1P₁-eGFP knock-in mice. 2011 Nat. Chem. Biol. pmid:21445057
Schultz C Lipid-induced phenotypes. 2006 Nat. Chem. Biol. pmid:16850012
Fyrst H and Saba JD An update on sphingosine-1-phosphate and other sphingolipid mediators. 2010 Nat. Chem. Biol. pmid:20559316
Ratner M Novartis eyes oral MS drug as potential blockbuster. 2010 Nat. Biotechnol. pmid:21057464
Kunkel GT et al. Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond. 2013 Nat Rev Drug Discov pmid:23954895
Nussbaum C et al. Sphingosine-1-phosphate receptor 3 promotes leukocyte rolling by mobilizing endothelial P-selectin. 2015 Nat Commun pmid:25832730
Chen LY et al. The Arabidopsis alkaline ceramidase TOD1 is a key turgor pressure regulator in plant cells. 2015 Nat Commun pmid:25591940
Keller J et al. Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts. 2014 Nat Commun pmid:25333900
Silva VR et al. Hypothalamic S1P/S1PR1 axis controls energy homeostasis. 2014 Nat Commun pmid:25255053
Hirata N et al. Sphingosine-1-phosphate promotes expansion of cancer stem cells via S1PR3 by a ligand-independent Notch activation. 2014 Nat Commun pmid:25254944
Deng Z et al. Enterobacteria-secreted particles induce production of exosome-like S1P-containing particles by intestinal epithelium to drive Th17-mediated tumorigenesis. 2015 Nat Commun pmid:25907800
Kassmer SH et al. Migration of germline progenitor cells is directed by sphingosine-1-phosphate signalling in a basal chordate. 2015 Nat Commun pmid:26456232
Vettorazzi S et al. Glucocorticoids limit acute lung inflammation in concert with inflammatory stimuli by induction of SphK1. 2015 Nat Commun pmid:26183376
Kajimoto T et al. Ongoing activation of sphingosine 1-phosphate receptors mediates maturation of exosomal multivesicular endosomes. 2013 Nat Commun pmid:24231649
Arce FT et al. Heterogeneous elastic response of human lung microvascular endothelial cells to barrier modulating stimuli. 2013 Nanomedicine pmid:23523769
Peng P et al. [Effect of sphingosine-1-phosphate on chemotherapy-induced ovarian damage and on the efficacy of chemotherapy in mice bearing S180 tumor]. 2012 Nan Fang Yi Ke Da Xue Xue Bao pmid:22445989
Massberg S and von Andrian UH Fingolimod and sphingosine-1-phosphate--modifiers of lymphocyte migration. 2006 N. Engl. J. Med. pmid:16971715
Kipp M and Amor S FTY720 on the way from the base camp to the summit of the mountain: relevance for remyelination. 2012 Mult. Scler. pmid:22383435
Hernandez F et al. Local effects of the sphingosine 1-phosphate on prostaglandin F2alpha-induced luteolysis in the pregnant rat. 2009 Mol. Reprod. Dev. pmid:19645054
Murakami A et al. Sphingosine 1-phosphate (S1P) regulates vascular contraction via S1P3 receptor: investigation based on a new S1P3 receptor antagonist. 2010 Mol. Pharmacol. pmid:20097776
Florio T et al. Basic fibroblast growth factor activates endothelial nitric-oxide synthase in CHO-K1 cells via the activation of ceramide synthesis. 2003 Mol. Pharmacol. pmid:12527801
Himmel HM et al. Guanine nucleotide-sensitive inhibition of L-type Ca2+ current by lysosphingolipids in RINm5F insulinoma cells. 1998 Mol. Pharmacol. pmid:9584212
Sato K et al. Possible involvement of cell surface receptors in sphingosine 1-phosphate-induced activation of extracellular signal-regulated kinase in C6 glioma cells. 1999 Mol. Pharmacol. pmid:9882706
Chin TY et al. Distinct effects of different calcium-mobilizing agents on cell death in NG108-15 neuroblastoma X glioma cells. 2002 Mol. Pharmacol. pmid:11854428
Tigyi G Selective ligands for lysophosphatidic acid receptor subtypes: gaining control over the endothelial differentiation gene family. 2001 Mol. Pharmacol. pmid:11723220
Damirin A et al. Sphingosine 1-phosphate receptors mediate the lipid-induced cAMP accumulation through cyclooxygenase-2/prostaglandin I2 pathway in human coronary artery smooth muscle cells. 2005 Mol. Pharmacol. pmid:15625281
Park KS et al. Lysophosphatidylserine stimulates L2071 mouse fibroblast chemotactic migration via a process involving pertussis toxin-sensitive trimeric G-proteins. 2006 Mol. Pharmacol. pmid:16368894
Deng Q et al. Identification of Leu276 of the S1P1 receptor and Phe263 of the S1P3 receptor in interaction with receptor specific agonists by molecular modeling, site-directed mutagenesis, and affinity studies. 2007 Mol. Pharmacol. pmid:17170199
Alqinyah M et al. Regulator of G Protein Signaling 10 (Rgs10) Expression Is Transcriptionally Silenced in Activated Microglia by Histone Deacetylase Activity. 2017 Mol. Pharmacol. pmid:28031332
Alemany R et al. Stimulation of sphingosine-1-phosphate formation by the P2Y(2) receptor in HL-60 cells: Ca(2+) requirement and implication in receptor-mediated Ca(2+) mobilization, but not MAP kinase activation. 2000 Mol. Pharmacol. pmid:10953041
Himmel HM et al. Evidence for Edg-3 receptor-mediated activation of I(K.ACh) by sphingosine-1-phosphate in human atrial cardiomyocytes. 2000 Mol. Pharmacol. pmid:10908314
Jiang LI et al. Regions on adenylyl cyclase VII required for selective regulation by the G13 pathway. 2013 Mol. Pharmacol. pmid:23229509
Kang JS et al. Glabridin suppresses intercellular adhesion molecule-1 expression in tumor necrosis factor-alpha-stimulated human umbilical vein endothelial cells by blocking sphingosine kinase pathway: implications of Akt, extracellular signal-regulated kinase, and nuclear factor-kappaB/Rel signaling pathways. 2006 Mol. Pharmacol. pmid:16354764
Pettus BJ et al. The coordination of prostaglandin E2 production by sphingosine-1-phosphate and ceramide-1-phosphate. 2005 Mol. Pharmacol. pmid:15900018
Van Koppen CJ et al. A distinct G(i) protein-coupled receptor for sphingosylphosphorylcholine in human leukemia HL-60 cells and human neutrophils. 1996 Mol. Pharmacol. pmid:8649355
Berger A et al. Structural requirements of sphingosylphosphocholine and sphingosine-1-phosphate for stimulation of activator protein-1 activity. 1996 Mol. Pharmacol. pmid:8794881
Sorensen SD et al. Common signaling pathways link activation of murine PAR-1, LPA, and S1P receptors to proliferation of astrocytes. 2003 Mol. Pharmacol. pmid:14573770
Baudhuin LM et al. Akt activation induced by lysophosphatidic acid and sphingosine-1-phosphate requires both mitogen-activated protein kinase kinase and p38 mitogen-activated protein kinase and is cell-line specific. 2002 Mol. Pharmacol. pmid:12181443
Roch L et al. High-Resolution Expression Profiling of Peripheral Blood CD8 Cells in Patients with Multiple Sclerosis Displays Fingolimod-Induced Immune Cell Redistribution. 2017 Mol. Neurobiol. pmid:27631876
Czubowicz K et al. Sphingosine-1-phosphate and its effect on glucose deprivation/glucose reload stress: from gene expression to neuronal survival. 2015 Mol. Neurobiol. pmid:25056275
Zhu Y et al. Vitamin D therapy in experimental allergic encephalomyelitis could be limited by opposing effects of sphingosine 1-phosphate and gelsolin dysregulation. 2014 Mol. Neurobiol. pmid:24722820
Czubowicz K and Strosznajder R Ceramide in the molecular mechanisms of neuronal cell death. The role of sphingosine-1-phosphate. 2014 Mol. Neurobiol. pmid:24420784
Pyszko J and Strosznajder JB Sphingosine kinase 1 and sphingosine-1-phosphate in oxidative stress evoked by 1-methyl-4-phenylpyridinium (MPP+) in human dopaminergic neuronal cells. 2014 Mol. Neurobiol. pmid:24399507
Custódio R et al. Characterization of secreted sphingosine-1-phosphate lyases required for virulence and intracellular survival of Burkholderia pseudomallei. 2016 Mol. Microbiol. pmid:27632710
Zhang O et al. Sphingosine kinase A is a pleiotropic and essential enzyme for Leishmania survival and virulence. 2013 Mol. Microbiol. pmid:23980754
Finney CA et al. S1P is associated with protection in human and experimental cerebral malaria. 2011 Mol. Med. pmid:21556483
Schaper K et al. Sphingosine-1-phosphate differently regulates the cytokine production of IL-12, IL-23 and IL-27 in activated murine bone marrow derived dendritic cells. 2014 Mol. Immunol. pmid:24434636
Schröder M et al. The sphingosine kinase 1 and S1P1 axis specifically counteracts LPS-induced IL-12p70 production in immune cells of the spleen. 2011 Mol. Immunol. pmid:21435724
Oskeritzian CA Mast cell plasticity and sphingosine-1-phosphate in immunity, inflammation and cancer. 2015 Mol. Immunol. pmid:24766823
Ryser MF et al. S1P(1) overexpression stimulates S1P-dependent chemotaxis of human CD34+ hematopoietic progenitor cells but strongly inhibits SDF-1/CXCR4-dependent migration and in vivo homing. 2008 Mol. Immunol. pmid:18760838
Kuchler L et al. Elevated intrathymic sphingosine-1-phosphate promotes thymus involution during sepsis. 2017 Mol. Immunol. pmid:28846923
Jolly PS et al. The roles of sphingosine-1-phosphate in asthma. 2002 Mol. Immunol. pmid:12217390